Cross-border deals fail for predictable reasons. After advising on transactions across the USA, India, Europe and the GCC since 2015, we see the same three deal-killers repeat — and none of them is valuation.

The first is documentation readiness. An overseas acquirer or investor assumes your data room matches the standard of their home market. Indian growth companies are often excellent businesses with informal paper: unsigned board minutes, related-party transactions that were never documented, ESOP pools approved verbally. None of this is fatal — but discovered mid-diligence, each item costs weeks and trust. Discovered before the process starts, each is a one-day fix.

The second is regulatory sequencing. Every corridor has its own choreography — pricing guidelines and deferred-consideration limits on Indian share transfers, merger-control thresholds in Europe, foreign-investment screening in the US. Deals die when the sequencing is discovered late and a structure everyone agreed to commercially turns out to need six months of approvals nobody budgeted for. The structure should be designed around the regulatory path, not retrofitted to it.

The third is the unmanaged middle. A cross-border process has two negotiations: the one between the parties, and the one inside each party — between the founder and their board, between the acquirer’s deal team and their investment committee. Most stalls we are brought in to revive happen because nobody owned the middle: weekly cadence, an issues list that actually closes, and one person responsible for keeping both sides’ decision-makers current.

What closes deals is the mirror image: a data room built to the buyer’s standard before launch, a structure designed by people who have run that specific corridor before, and disciplined process management from kickoff to signing. It is unglamorous work. It is also why completion ratios differ so much between advisors — ours has run at 64% across 126 transactions, in a market where most processes quietly die.